Target intelligence / Profile preview

MRAP antisense RNA 1 (MRAP-AS1)

Target
MRAP-AS1
Molecular classification
Long noncoding RNA (lncRNA), Antisense RNA, Other
01

Overview

MRAP antisense RNA 1 (MRAP-AS1) is a long noncoding RNA (lncRNA) gene transcribed antisense to the MRAP (melanocortin 2 receptor accessory protein) gene. MRAP-AS1 belongs to the lncRNA class and, as implied by its name, is likely involved in the regulation of MRAP gene expression or chromatin structure. There are currently no published reports of MRAP-AS1 directly mediating a therapeutic effect or being a validated drug target. Antisense lncRNAs often participate in local or global gene regulation by mechanisms including transcriptional interference, chromatin modification, or post-transcriptional control, but specific biological roles, interacting drugs, or utility as a biomarker or therapeutic target for MRAP-AS1 remain to be established in the published literature[3][5]. Diseases associated with MRAP-AS1 are tentatively linked through its locus, such as glucocorticoid deficiency, likely reflecting the function of the adjacent MRAP gene rather than its own independent role[5]. There is frequent confusion between MRAP-AS1 (an RNA gene/lncRNA) and MRAP (a protein-coding gene for a receptor accessory protein); these are distinct molecular entities with different functions and druggability. MRAP-AS1 itself shows no evidence of being a direct therapeutic target, nor is there evidence of it being a protein, receptor, or enzyme[5][3].

Other names
MRAP-AS1MRAP antisense RNA 1
02

Biological functions

Regulation of gene expressionPossible chromatin modificationPotential regulation of adjacent gene (MRAP)
03

Disease associations

Possible involvement in glucocorticoid deficiency (from locus association)Other

Beyond the preview

Go deeper on MRAP antisense RNA 1 (MRAP-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MRAP antisense RNA 1 (MRAP-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call